You are here: Industry Insights > Parkinson’s

News List

Ben-Gurion University discover new drug candidates for Parkinson’s Disease expresspharma
January 29, 2021
Researchers discovered that proteins called BMP5/7 can be administered to protect dopamine-producing brain cells, in a Parkinson’s disease mouse model.
BlueRock, Sloan Kettering Receive IND Clearance for DA01 for Parkinson’s Disease americanpharmaceuticalreview
January 14, 2021
BlueRock Therapeutics, a wholly-owned subsidiary of Bayer AG, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), announced the U.S. Food and Drug Administration (FDA) has cleared their Investigational New Drug (IND) application to ...
Collaboration to investigate nasal drug delivery using nanoparticle technology europeanpharmaceuticalreview
January 11, 2021
A new partnership aims to improve blood-brain-barrier penetration in the nasal drug delivery route for certain Parkinson’s therapies.
Parkinson’s UK partners with UCL on phase II trial pharmatimes
October 28, 2020
Parkinson’s UK has partnered with University College London (UCL) and will invest £1m in a phase II clinical trial to investigate if the drug ondansetron can alleviate hallucinations in people with Parkinson’s disease.
Space study seeks treatments for Parkinson’s, multiple sclerosis expresspharma
August 05, 2019
Scientists are conducting a first-of-its-kind study on the International Space Station (ISS) to find the causes and treatment of major neurodegenerative diseases such as Parkinson’s and multiple sclerosis.
Alembic Pharma gets US FDA nod for Parkinson’s treatment drug expressbpd
January 04, 2019
The approved product is a therapeutic equivalent to the reference listed drug product (RLD) Mirapex ER tablets, of Boehringer lngelheim Pharmaceuticals
New brain circuits formed for motor function after Parkinson’s therapy europeanpharmaceuticalreview
November 30, 2018
A gene therapy called AAV2-GAD has been associated with improved motor function, leading to researchers looking at its use in an upcoming Phase III trial…
Japan conducts world’s first iPS cell transplant for Parkinson’s biospectrum
November 12, 2018
The team intends to develop a mass production system that enables the delivery of nerve cells derived from iPS cells all over the world.
Immunosuppressant drugs may protect against Parkinson’s europeanpharmaceuticalreview
June 04, 2018
People who take immunosuppressants are less likely to develop Parkinson’s disease…
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated europeanpharmaceuticalreview
April 13, 2018
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies…

Previous page 1 2 Next page